How to Manage Wound Odor: Best Practices for Effective Wound Care

Wound odor is distressing for patients, families, and caregivers. It can reduce quality of life, cause social isolation, and signal underlying problems such as high bacterial load, necrosis, or infection. Fortunately, many practical, evidence-informed strategies help reduce malodor while supporting wound healing. This article explains why wounds smell, how clinicians assess odor, and the best current approaches to manage it; from dressings and topical agents to debridement and systemic care.

Why wounds smell (simple explanation)

Wound odor usually arises when organic material in the wound (necrotic tissue, blood, exudate) is broken down by bacteria. Anaerobic bacteria and some Proteobacteria produce volatile compounds (sulfides, amines, fatty acids) that carry a strong, often unpleasant smell. Other contributors include high exudate, poor perfusion, retained dressing material, and local tissue necrosis. Odor itself doesn’t always mean a systemic infection, but it often indicates increased bacterial activity or tissue breakdown that warrants assessment.

Goals of odor management

When treating a malodorous wound, clinicians typically aim to:

• Reduce the underlying cause (necrotic tissue, high bacterial load, uncontrolled exudate).

• Improve the wound environment to encourage healing (proper moisture balance, debridement).

• Reduce the smell using safe topical or dressing-based measures while avoiding harm.

• Support patient comfort and dignity (psychosocial impact).

These goals guide both immediate measures (topical deodorizing agents, odor-adsorbing dressings) and longer-term strategies (debridement, infection control, wound bed preparation).

Assessment: start with a focused clinical review

A clear assessment differentiates causes and helps choose priorities:

1. History: onset and pattern of odor, recent treatments, bleeding, pain, systemic symptoms (fever, malaise).

2. Wound inspection: amount/type of exudate, presence of slough or necrosis, tissue discoloration, signs of infection (increasing erythema, induration), and exposed bone or fistulae.

3. Microbiology and imaging: when infection is suspected or the wound is not responding, obtain appropriate cultures and consider imaging to rule out deep infection or osteomyelitis.

4. Patient factors: perfusion, glycemic control, nutrition, continence, and ability to offload or change dressings.

Assessment must be holistic: odor control without addressing the cause is usually temporary.

First-line clinical steps (practical, immediate actions)

These basic steps are often effective and should be done promptly:

1. Wound cleansing and appropriate debridement - remove necrotic tissue and fibrin that feed bacteria and produce malodor. Debridement method (sharp, enzymatic, autolytic, mechanical) depends on wound type, patient comorbidity, and clinician skill. Debridement often reduces odor by removing the substrate that bacteria metabolize.

2. Control exudate - use highly absorptive dressings (alginate, hydrofiber, superabsorbent) or negative pressure wound therapy (NPWT) for high-volume drainage. Excess exudate can worsen odor and macerate periwound skin.

3. Treat infection when present - systemic antibiotics are indicated for spreading or deep infection. Local antimicrobial measures (see below) may be used while systemic therapy proceeds as appropriate. Culture-directed therapy is preferred when possible.

4. Use odor-controlling dressings or topical agents - short-term adjuncts that can meaningfully reduce smell and improve patient comfort (details below).

Topical treatments and dressings that reduce odor

Multiple topical approaches are used in practice; evidence quality varies, but several options have consistent clinical support.

1) Topical metronidazole

Metronidazole targets anaerobic bacteria and has the most consistent evidence base for reducing malodor in chronic and malignant wounds. It’s available as a gel, spray, or crushed-tablet powder applied directly to the wound. Systematic reviews and clinical studies report that topical metronidazole can reduce odor relatively quickly and is generally well tolerated. Dosing and formulations vary across studies, and local protocols differ. Follow local formularies and consider allergy or interaction risks.

Practical note: use metronidazole when anaerobic infection or heavy odor is suspected, and monitor response. It is an adjunct, not a substitute for debridement or systemic therapy when those are needed.

2) Activated charcoal (carbon) dressings

Charcoal dressings adsorb volatile molecules and can reduce perceived odor without systemic effects. Some randomized and observational studies indicate charcoal-based dressings reduce malodor and are useful when odor is a prominent symptom. They’re often used as primary dressings or as an overlay on exudate-managing layers. Charcoal does not treat infection itself but can improve comfort while other therapies address the cause.

3) Cadexomer iodine (CI) and other topical iodophors

Cadexomer iodine can reduce bioburden, slough, and exudate and has been associated with odor reduction in clinical studies and systematic reviews. CI slowly releases iodine, which has broad antimicrobial action and may help shift heavily contaminated wounds toward a cleaner bed. Use with caution in patients with iodine sensitivity or thyroid disease and follow product guidance.

4) Hypertonic saline dressings (e.g., Mesalt)

Hypertonic sodium chloride dressings pull fluid from the wound and may assist odor control through exudate reduction and wound cleansing; some evidence supports benefit for malodorous malignant fungating wounds and chronic exuding wounds.

5) Other topical agents (honey, silver, sugar, essential oils, curcumin)

These have varying levels of evidence. Medical-grade honey has antimicrobial activity and can reduce odor in some wounds; silver dressings may reduce bacterial load but evidence specific to odor varies. Natural agents (curcumin, essential oils) appear in some small studies but require more robust trials before wide endorsement. Use clinical judgment and local guidance when considering these options.

Devices and advanced options

• Activated charcoal with absorptive layers: combines odor adsorption with exudate control; useful in moderately to heavily exuding but malodorous wounds.

• Negative Pressure Wound Therapy (NPWT): for deep or heavily exuding wounds, NPWT can reduce exudate volume, control bacterial bioburden in some cases, and improve wound environment; it may indirectly reduce odor when used appropriately. NPWT is a specialist-level intervention and requires training and follow-up.

• Topical antimicrobials embedded in dressings (e.g., iodine-impregnated dressings): may reduce odor through bioburden control over days rather than hours.

Special case: malignant fungating wounds (MFW)

Malignant fungating wounds often produce severe malodor, heavy exudate, and bleeding. Evidence about best approaches is limited but indicates that a combination of debridement where safe, absorptive dressings, topical metronidazole, cadexomer iodine, and activated charcoal can each play a role. Palliative priorities such as comfort, odor control, and quality of life guide interventions; invasive procedures may not be appropriate depending on prognosis. Use multidisciplinary palliative input for these cases.

Practical algorithm (simple, clinic-ready)

1. Assess: inspect wound, check for infection/deep tissue involvement, assess perfusion and comorbidities.

2. Debride necrotic tissue if clinically appropriate (sharp, enzymatic, or autolytic). Reduction of devitalized tissue often reduces odor.

3. Manage exudate: choose absorbent dressing (alginate/hydrofiber/foam/superabsorbent) and consider NPWT for deep/very exuding wounds.

4. Apply odor-targeted therapy: use topical metronidazole, activated charcoal dressing, or cadexomer iodine according to the clinical context and product guidance. Monitor response.

5. Treat infection systemically when indicated (culture-directed antibiotics).

6. Supportive care: protect periwound skin, manage pain, provide psychosocial support, and educate patient/caregiver about dressing care and when to seek help.

Practical tips for nurses and caregivers

• Use a combination approach: a dressing that manages exudate plus a charcoal overlay or short-course topical metronidazole often works well.

• Document odor qualitatively (e.g., none/mild/moderate/severe) and note response to interventions—objective scales exist in some settings.

• When using topical metronidazole, follow local dosing guidance and monitor for skin irritation. Avoid prolonged use without reassessment.

• Ensure good hygiene and ventilation in care settings; consider discreet measures for visitors (scent-free rooms, distance, mask for severely odorous wounds) while preserving dignity.

Evidence quality and limitations

Systematic reviews show several interventions reduce odor (topical metronidazole, activated charcoal, cadexomer iodine, hypertonic dressings), but many studies are small, heterogeneous, or not randomized. Measurement of odor is often subjective and lacks standardization. Therefore, while multiple strategies appear effective in clinical practice, clinicians should combine evidence with local protocols and individual patient needs. Continued research into standardized outcome measures for odor and larger trials of topical agents would strengthen recommendations.

Final thoughts

Wound odor is distressing but often manageable with a clear, stepwise approach: assess thoroughly, remove devitalized tissue, control exudate, treat infection if present, and use topical or dressing-based odor control as an adjunct. Topical metronidazole, activated charcoal dressings, and cadexomer iodine are among the options with consistent clinical support. Always prioritize patient comfort and dignity and work with a multidisciplinary team when wounds are complex or when palliative goals predominate.

See also

How to Tell If a Wound Is Healing: Signs of Proper Wound Care Progress
Best Practices for Chronic Wound Care: How to Assess Foot Ulcers Effectively
Why Diabetic Foot Wounds Heal Slowly: Top Factors That Delay Recovery
How Often Should Wound Dressings Be Changed? Best Practices for Healing
Best Wound Dressings for High-Exudate Wounds

More Information

For more information on the latest effective wound care, contact us to set up a time for a call.

Sources

1. da Costa Santos, et al. 2010 - A systematic review of topical treatments to control the odor of malignant fungating wounds. Journal of Pain and Symptom Management
   https://www.jpsmjournal.com/article/S0885-3924(10)00246-0/fulltext

2. de Castro DLV, et al. 2015 - Controlling wound odor with metronidazole: a systematic review. Scielo Brazil
   https://www.scielo.br/j/reeusp/a/CfPXktFWRDBD74HfW9DKrsy/?lang=en

3. Akhmetova A, et al. 2016 - A comprehensive review of topical odor-controlling treatment options for chronic wounds. Journal of Wound, Ostomy, and Continence Nursing
   https://journals.lww.com/jwocnonline/fulltext/2016/11000/a_comprehensive_review_of_topical_odor_controlling.4.aspx

4. Black J, Berke C. 2023 - Ten Top Tips: Managing wound odour. Wounds International
   https://woundsinternational.com/wp-content/uploads/2023/02/afdb977c6c855bc27ed43ffa56e3c746.pdf

5. Woo K, et al. 2021 - Efficacy of topical cadexomer iodine treatment in chronic wounds: Systematic review... International Wound Journal
   https://woundinfectionawareness.com/wp-content/uploads/2022/10/International-Wound-Journal-2021-Woo-Efficacy-of-topical-cadexomer-iodine-treatment-in-chronic-wounds-Systematic.pdf

6. Hayashida K, Yamakawa S. 2021 - Topical odour management in burn patients. Oxford University Press
   https://academic.oup.com/burnstrauma/article/doi/10.1093/burnst/tkab025/6357884

7. U of Illinois Chicago College of Pharmacy, 2025 - How should metronidazole be used for chronic wound odor?
   https://dig.pharmacy.uic.edu/faqs/2025-2/april-2025-faqs/how-should-metronidazole-be-used-for-chronic-wound-odor/ Drug Information Group

8. Koumaki D, et al. 2023 - A narrative review of management of wounds in palliative care setting. Annals of Palliative Medicine

   https://apm.amegroups.org/article/view/117437/html

* This blog is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.